Loading...
  • Motion
  • Marker distribution tests indicated that greater than 80% of the calculated marker positions fell into the high cross correlation and high motion magnitude regions for both of the algorithms. (osti.gov)
  • positions
  • The second stage is to determine the "best represented" columns of the eigenvector matrix obtained from stage one and subsequently acquire the optimal marker positions as well as numbers. (osti.gov)
  • biopsy
  • If you agree to take part in this study, 3 markers will be permanently implanted into your prostate using a needle similar to the biopsy needle used to diagnose your cancer. (knowcancer.com)
  • The purpose of the study was to describe and present outcomes of the track embolization technique with absorbable hemostat gelatin powder during percutaneous computed tomography (CT)-guided lung biopsy and/or fiducial marker placement versus the standard of care (no track embolization) in an attempt to decrease rates of pneumothorax (PTX), chest tube placement, hemorrhage and/or complications, and average cost per patient. (naver.com)
  • A biopsy site marker comprises small bodies or pellets of gelatin which enclose substantially in their interior a radio (X-ray) opaque object. (google.de)
  • 7. The biopsy site marker of claim 1 wherein the at least one marker body is formed of a bioabsorbable material selected from the group consisting of gelatin or collagen. (google.de)
  • 8. The biopsy site marker of claim 7 wherein the collagen is renatured, cross-linked collagen. (google.de)
  • wherein
  • 2. The system of claim 1 wherein the at least one marker body is slidably disposed within the inner lumen. (google.de)
  • 4. The system of claim 1 wherein at least one marker body is solid at a temperature of 40 C. (google.de)
  • 5. The system of claim 1 wherein at least one marker body is ultrasonically detectable. (google.de)
  • 6. The system of claim 1 wherein at least one marker body has a colorant incorporated therein. (google.de)
  • 11. The system of claim 1 wherein the at least one marker body has radiographically detectable metallic ion bound to the bioabsorbable material. (google.de)
  • 12. The system of claim 1 wherein the marker body has a Bloom strength of at least 150. (google.de)
  • 13. The system of claim 1 wherein the marker body has a Bloom strength of not more than 300. (google.de)
  • 15. The system of claim 1 wherein the marker body has a Bloom strength of about 250 to about 300. (google.de)
  • 14 . The device of claim 1 wherein the marker is located within an interior of the at least one body. (google.com)
  • 15 . The device of claim 1 wherein the marker is substantially located within a geometric center of the at least one body. (google.com)
  • 19 . The device of claim 1 wherein the marker has a form of a sphere. (google.com)
  • 24 . The device of claim 1 wherein the marker has a distinguishing mark. (google.com)
  • 25 . The device of claim 1 wherein the marker is fixedly attached to the at least one body. (google.com)
  • 27 . The device of claim 1 wherein the marker is radioactive. (google.com)
  • 13 . The intracorporeal site marker delivery system of claim 12 wherein the pellets exhibiting hemostatic properties are formed at least in part of suitable polysaccharide. (google.com.au)
  • 14 . The intracorporeal site marker delivery system of claim 13 wherein the polysaccharide is starch. (google.com.au)
  • wherein acquiring image data includes imaging the member that includes the fiducial marker. (google.es)
  • 5 . The method of claim 3 , wherein forming a template of a fiducial marker includes defining a computer readable template operable to be compared to the acquired image data by executing instructions with a processor. (google.es)
  • wherein forming the list includes including candidate fiducial points having a score of at least the threshold score. (google.es)
  • tissue
  • Using appropriately powered experiments in mouse models, we will characterise the fiducial marker in multiple tumour and normal tissue sites and determine impacts on radiobiological response. (nc3rs.org.uk)
  • CBCT
  • Lipiodol-glue combinations were successfully administered as multiple fiducials that were evident on CT and CBCT. (springer.com)
  • Within the framework of the NC3Rs we will initially replace in vivo characterisation of our marker with in phantom measurements of CBCT and MRI image contrast enhancement. (nc3rs.org.uk)
  • alignment
  • This approach remains challenging in animal models given the small target volumes, however, using a minimally invasive injectable marker provides an optimal solution to improve target alignment. (nc3rs.org.uk)
  • contrast agents
  • Fiducial capillary tubes filled with mixed contrast agents are frequently used to facilitate cross-platform imaging and we later employed capillary tubes filled with contrast agents. (bruker.com)
  • position
  • Embodiments of improved systems and processes for cutting knee bones during computer assisted knee surgery are provided, comprising at least one fiducial associated with the guiding device and a tracking functionality capable of tracking a position and orientation of the at least one fiducial. (google.es)
  • a tracking functionality capable of tracking a position and orientation of the at least two fiducials. (google.es)
  • bioabsorbable material
  • This is further a method of marking a subcutaneous cavity using a bioabsorbable material and a bioabsorbable or non-bioabsorbable marker in conjunction with the material. (google.com)
  • small
  • They are typically placed in a small hole in the bone and sealed with bone wax, with no marker migration. (civcort.com)
  • optimal
  • The second stage is to determine the "best represented" columns of the eigenvector matrix obtained from stage one and subsequently acquire the optimal marker positions as well as numbers. (osti.gov)
  • delivery
  • The Lipiodol Glubran2 combination was deemed subjectively easiest to use at delivery, and a better fiducial on KV imaging. (springer.com)
  • c) a plunger which is slidably disposed in part within the inner lumen of the delivery cannula proximal to the at least one marker body and which is configured to move the at least one marker body up the ramp and out of the discharge port in the delivery cannula. (google.de)
  • high
  • The present invention also relates tothe identification of markers with high sensitivity andspecificity for the prognosis of SMA, prognosticmethods including the use of such markers andprognostic kits. (iit.it)